|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Agencourt Bioscience Corporation, Affymetrix Clinical Services Lab and NuGEN Technologies, Inc. Collaborate to Accelerate Automated Clinical Whole Blood Sample Expression Profiling on GeneChip® Microarrays
4/25/2007 1:47:36 PM
FULLERTON, SAN CARLOS & WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Agencourt Bioscience, a wholly-owned subsidiary of Beckman Coulter, Inc., NuGEN Technologies, Inc., and Affymetrix Clinical Services Laboratory (ACSL) today announced a collaboration that has yielded a service offering for the automated isolation and target preparation of RNA from whole blood samples collected, stabilized, and stored in PAXgene Blood Tubes. The service offering enables expression analysis profiling using Affymetrix GeneChip® technology and is valuable for pharmaceutical companies focused on drug discovery and development. It is also useful for government agencies conducting biomarker discovery and cancer research and for academic centers of excellence and core labs where rapid, high-throughput applications are critical.
|
|
|
|
|
|
|
|
|
|
|